Express Scripts (ESRX) Guides FY16 EPS Above Expectations

Go back to Express Scripts (ESRX) Guides FY16 EPS Above Expectations

Express Scripts Holding Company Announces 2016 Financial Guidance and Reaffirms 2015 Financial Guidance

December 22, 2015 7:00 AM UTC

ST. LOUIS, Dec. 22, 2015 /PRNewswire/ -- Express Scripts Holding Company (Nasdaq: ESRX) anticipates achieving adjusted earnings per diluted share for 2016 in the range of $6.08 to $6.28, representing growth of 10% to 14% over the mid-point of our previously issued 2015 guidance range See table below.

"Our focused model of alignment has positioned us uniquely in the healthcare services landscape to improve health outcomes and lower costs for our clients and patients," said George Paz, CEO and chairman of Express Scripts.  "No one matches our focus on serving clients and patients and we remain confident in our... More